- CA$106.02m
- CA$132.76m
- CA$320.51m
- 73
- 96
- 51
- 85
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 284 | 463 | 663 | 359 | 321 |
Cost of Revenue | |||||
Gross Profit | 9.05 | 20.3 | 27.2 | 23.5 | 34.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 267 | 464 | 658 | 366 | 309 |
Operating Profit | 16.8 | -0.227 | 5.26 | -6.92 | 11.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22 | -9.44 | 12.5 | -5.62 | 7.88 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21.7 | -9.71 | 11.7 | -6.06 | 6.69 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 23.6 | -9.71 | 11.7 | -5.75 | 6.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.6 | -9.71 | 11.7 | -5.75 | 6.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.187 | -0.661 | 0.81 | 0.212 | 0.992 |